vrbl	or	l95	u95	p	disp	y
industry	0.3188884588582783	0.16920084161228136	0.563694357149629	1.2007521919860888e-5	industry-sponsored	8
drug	0.593111621935022	0.3781832328948069	0.9253532995175643	0.016550513932702456	drug	7
behav	3.1017687717644633	1.9808049252864932	4.84928502444906	3.820228276503751e-7	behavioral	6
device	0.26045320446037984	0.06908279406068363	0.696676733012926	0.0024032833533667182	device	5
proced	0.6120826175142985	0.07208055169334998	2.330743439283393	0.7704755668148043	procedure	4
pspec	0.6707402230342747	0.4283627991198575	1.0460141852460256	0.06624355044955368	specified phase	3
complete	0.8163899765614663	0.5226375739676412	1.273076746908378	0.3890433507046898	completed	2
has_placebo	1.0213587319446649	0.6472918077378487	1.597492848442314	0.9135346664670818	placebo-controlled	1
